Top Buy
| Wertpapier | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| QIAGEN NV | 12 | 0 | 1 | 0 | 40,47 € | 47,52 € | 17,42 % |
| Verastem Inc. | 12 | 0 | 2 | 0 | 2,30 € | 17,56 € | 663,30 % |
| Rigel Pharmaceutical Inc. | 13 | 0 | 1 | 0 | 0,74 € | 13,86 € | 1772,36 % |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | 15,09 € | 24,44 € | 61,93 % |
| Incyte Corp. | 13 | 2 | 2 | 0 | 59,08 € | 77,67 € | 31,47 % |
| MacroGenics Inc. | 13 | 0 | 2 | 0 | 3,50 € | 11,86 € | 238,39 % |
| Sangamo Therapeutics Inc. | 14 | 17 | 2 | 4 | 0,79 € | 4,57 € | 477,60 % |
| Rhythm Pharmaceuticals | 14 | 0 | 1 | 0 | 40,40 € | 46,19 € | 14,32 % |
| PTC Therapeutics Inc. | 14 | 9 | 0 | 0 | 29,00 € | 41,46 € | 42,98 % |
| Xencor Inc. | 15 | 1 | 1 | 0 | 17,50 € | 31,65 € | 80,88 % |
| Bayer AG | 15 | 3 | 2 | 2 | 27,33 € | 45,00 € | 64,68 % |
| Repligen Corp. | 15 | 0 | 4 | 0 | 148,20 € | 178,01 € | 20,12 % |
| Esperion Therapeutis.Inc. | 16 | 1 | 1 | 0 | 1,88 € | 10,00 € | 430,93 % |
| Stoke Therapeutics Inc | 16 | 1 | 1 | 0 | 13,70 € | 20,51 € | 49,71 % |
| Medpace Holdings Inc | 16 | 0 | 5 | 0 | 345,50 € | 418,12 € | 21,02 % |
| BioMarin Pharmaceutical Inc. | 16 | 0 | 1 | 0 | 77,16 € | 102,54 € | 32,90 % |
| Exact Sciences | 17 | 0 | 2 | 0 | 52,56 € | 75,89 € | 44,39 % |
| Geron Corp. | 17 | 0 | 1 | 0 | 4,20 € | 5,56 € | 32,28 % |
| Alkermes plc | 17 | 2 | 3 | 0 | 24,40 € | 35,01 € | 43,50 % |
| Corcept Therapeutics Inc. | 17 | 0 | 2 | 0 | 35,19 € | 37,08 € | 5,37 % |
| Krystal Biotech | 17 | 0 | 0 | 0 | 175,80 € | 182,79 € | 3,98 % |
| Celldex Therapeutics | 18 | 1 | 3 | 0 | 32,00 € | 62,02 € | 93,80 % |
| Akero Therapeutics Inc | 18 | 0 | 0 | 0 | 24,61 € | 38,62 € | 56,94 % |
| Abbott Laboratories | 19 | 0 | 1 | 0 | 101,98 € | 116,25 € | 13,99 % |
| EyePoint Pharmaceuticals Inc. | 19 | 1 | 0 | 0 | 8,14 € | 28,29 € | 247,60 % |